AU2003217024A1 - Combination comprising a cdk inhibitor and doxorubicin - Google Patents

Combination comprising a cdk inhibitor and doxorubicin

Info

Publication number: AU2003217024A1
Authority: AU; Australia
Prior art keywords: doxorubicin; combination; cdk inhibitor; cdk; inhibitor
Prior art date: 2002-03-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003217024A

Inventor

Anton Berns

Helen Mary Coley

Scott Lyons

Roger Neil Sleigh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cyclacel Ltd

Original Assignee

Cyclacel Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-27

Filing date

2003-03-25

Publication date

2003-10-13

2002-03-27 Priority claimed from GB0207228A external-priority patent/GB0207228D0/en

2002-09-26 Priority claimed from GB0222408A external-priority patent/GB0222408D0/en

2002-11-06 Priority claimed from GB0225876A external-priority patent/GB0225876D0/en

2003-03-25 Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd

2003-10-13 Publication of AU2003217024A1 publication Critical patent/AU2003217024A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003217024A 2002-03-27 2003-03-25 Combination comprising a cdk inhibitor and doxorubicin Abandoned AU2003217024A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
GB0207228.8		2002-03-27
GB0207228A GB0207228D0 (en)	2002-03-27	2002-03-27	Use
GB0222408.7		2002-09-26
GB0222408A GB0222408D0 (en)	2002-09-26	2002-09-26	Use
GB0225876A GB0225876D0 (en)	2002-11-06	2002-11-06	Use
GB0225876.2		2002-11-06
PCT/GB2003/001282 WO2003082337A1 (en)	2002-03-27	2003-03-25	Combination comprising a cdk inhibitor and doxorubicin

Publications (1)

Publication Number	Publication Date
AU2003217024A1 true AU2003217024A1 (en)	2003-10-13

Family

ID=28678579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003217024A Abandoned AU2003217024A1 (en)	2002-03-27	2003-03-25	Combination comprising a cdk inhibitor and doxorubicin

Country Status (7)

Country	Link
EP (1)	EP1487495A1 (en)
JP (1)	JP2005527560A (en)
CN (1)	CN1655821A (en)
AU (1)	AU2003217024A1 (en)
BR (1)	BR0308756A (en)
MX (1)	MXPA04009396A (en)
WO (1)	WO2003082337A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1680123A1 (en) *	2003-11-06	2006-07-19	Cyclacel Limited	Use
GB0328180D0 (en) *	2003-12-04	2004-01-07	Cyclacel Ltd	Combination
WO2007132220A1 (en) *	2006-05-12	2007-11-22	Cyclacel Limited	Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder
CN103169720B (en) *	2011-12-21	2016-12-07	张雅珍	Anthracycline antibiotics and officinal salt purposes in the treatment retinal vein occlusion thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002228692A1 (en) *	2000-12-01	2002-06-11	Bristol-Myers Squibb Pharma Company	3-(2,4-dimethylthiazol-5-yl) indeno(1,2-c)pyrazol-4-one derivatives as cdk inhibitors
JP2004538247A (en) *	2000-12-08	2004-12-24	ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー	Semicarbazide and cyclin-dependent kinase inhibitors

2003
- 2003-03-25 EP EP03712412A patent/EP1487495A1/en not_active Withdrawn
- 2003-03-25 AU AU2003217024A patent/AU2003217024A1/en not_active Abandoned
- 2003-03-25 CN CNA038120852A patent/CN1655821A/en active Pending
- 2003-03-25 MX MXPA04009396A patent/MXPA04009396A/en unknown
- 2003-03-25 BR BR0308756-5A patent/BR0308756A/en not_active IP Right Cessation
- 2003-03-25 JP JP2003579873A patent/JP2005527560A/en not_active Withdrawn
- 2003-03-25 WO PCT/GB2003/001282 patent/WO2003082337A1/en not_active Ceased

Also Published As

Publication number	Publication date
BR0308756A (en)	2004-12-28
MXPA04009396A (en)	2005-01-25
JP2005527560A (en)	2005-09-15
EP1487495A1 (en)	2004-12-22
CN1655821A (en)	2005-08-17
WO2003082337A1 (en)	2003-10-09

Publication	Publication Date	Title
AU2003208967A1 (en)	2003-09-02	A combination for treating cold and cough
AU2003231752A1 (en)	2003-11-03	Tack and tack applier
AU2003300017A1 (en)	2004-07-29	Microprocessor and microprocessor operation
AU2003203029A1 (en)	2003-07-30	Improved health-related devices and methods
AU2003304426A1 (en)	2005-03-07	Quorum sensing and biofilm formation
AU2003283213A1 (en)	2004-06-23	A catheter
AU2003202270A1 (en)	2003-07-30	Integration integrity manager
AU2001264258A1 (en)	2001-12-24	Nonwoven-fabric laminate and use thereof
AU2003220437A1 (en)	2003-10-08	Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2001261750A1 (en)	2001-12-24	Laminate and its use
AU2002243386A1 (en)	2002-06-18	Rf2a and rf2b transcription factors
PL373692A1 (en)	2005-09-05	Pharmaceutical composition comprising a lipase inhibitor and glucomannan
AU2001255090A1 (en)	2001-11-12	Cdk inhibitors having 3-hydroxychromen-4-one structure
AU7458201A (en)	2002-01-02	Laminate and use thereof
AU2003205381A1 (en)	2003-09-02	Hpma-polyamine conjugates and uses therefore
AU2003298810A1 (en)	2004-08-23	NF-kB INHIBITORS AND USES THEREOF
AU2003283727A1 (en)	2004-07-14	Recording start and stop
AU2003262073A1 (en)	2004-04-08	Antitussives
AU2003281691A1 (en)	2004-02-16	Furoisoquinoline derivative and use thereof
AU2003231827A1 (en)	2003-12-12	Pseudo-tissues and uses thereof
AU2003217024A1 (en)	2003-10-13	Combination comprising a cdk inhibitor and doxorubicin
AU2003264189A1 (en)	2004-04-30	A wheel and a wheel disc
AU2003302173A1 (en)	2004-07-14	Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003267790A1 (en)	2004-04-19	Lipase inhibitors and uses thereof
AU2003269615A1 (en)	2004-05-13	A wheel and a wheel disc

Legal Events

Date	Code	Title	Description
2004-12-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase